Synvisc 3x2ml

Osteoarthritis is a persistent and degenerative joint condition that affects millions worldwide. Characterized by pain, stiffness, and reduced mobility, it can significantly hinder a patient’s quality of life. Despite ongoing medical advancements, osteoarthritis remains incurable – but not unmanageable. For patients who have not responded well to standard treatment approaches, intra-articular injections of hyaluronic acid-based products can offer a safe and effective path to relief.

Among the top solutions available in the modern medical market is Synvisc (3x2ml) – a trusted viscosupplement designed to alleviate knee joint pain in osteoarthritis patients. Manufactured by Sanofi, a globally renowned pharmaceutical company, Synvisc is a non-surgical, minimally invasive alternative for those seeking long-lasting relief from joint discomfort. This comprehensive overview of Synvisc (3x2ml) explores its key features, composition, indications, contraindications, treatment expectations, potential side effects, and post-treatment care recommendations, as well as where to buy it online. PLEASE NOTE: This article primarily talks about Synvisc (3x2ml). The Synvisc brand, however, offers one more product that deserves attention, – Synvisc One. This single-dose treatment works with osteoarthritis symptoms by restoring the elasticity of joint tissue and the improvement of its cartilage. It is oftentimes used to provide lubrication for a joint affected by osteoarthritis, especially if a patient has already tried a conservative nonpharmacologic therapy or the intake of simple analgesics but haven’t noticed any substantial results.

Key Features and Composition

The Synvisc gel is part of a class of treatments known as viscosupplement injections – products that mimic the synovial fluid naturally found in joints, helping to cushion and lubricate them. This synthetic substitute becomes particularly useful when the body’s own synovial fluid becomes thin or less effective due to degenerative conditions like osteoarthritis.

Key Features

What differentiates Synvisc (3x2ml) from numerous similar products used to treat osteoarthritis pain are the following peculiarities:

• It is a sterile, non-pyrogenic injectable gel based on hylan and sodium dihydrogen phosphate hydrate for intra-articular use;
• Synvics (3x2ml) is conveniently packaged as 3 syringes, each containing 2ml of injectable solution;
• The product is designed for use in three separate doses, administered one week apart;
• It provides relief lasting up to six months after a full treatment cycle;
• Synvisc is developed and manufactured by Sanofi, ensuring pharmaceutical-grade quality and safety.

Composition

The active ingredient in Synvisc is Hylan G-F 20, a high molecular weight derivative of hyaluronic acid (HA). Hyaluronic acid is a naturally occurring polysaccharide found in synovial fluid, where it functions to cushion and lubricate the joints. Hylan G-F 20 consists of:

• Hylan A fluid (a soluble component);
• Hylan B gel (an insoluble component);
• Sodium chloride solution for isotonicity;
• Buffered with phosphate to maintain pH balance.

It is also worth mentioning that hylan polymers in Synvisc are derived from avian sources, specifically purified from rooster combs. It is a pretty common and effective method for obtaining hyaluronic acid-like substances. PLEASE NOTE: Hyaluronic acid is a natural substance found throughout various body tissues. If a healthcare provider manages to inject its substitutes into joints affected by osteoarthritis, they might function as a temporary replacement for the lack of synovial fluid and, therefore, reduce the symptoms causing pain.

Indications

Synvisc (3x2ml) is indicated for the treatment of osteoarthritis-related joint pain, specifically in the knee. It is especially recommended for:

• Patients with mild to moderate osteoarthritis;
• Individuals who have not responded adequately to more conservative therapy, such as physical therapy, intake of oral analgesics (for instance, acetaminophen, NSAIDs, and so on), or non-drug treatment options, such as weight loss programs and lifestyle changes.

Synvisc is not intended as a first-line therapy but as an effective next step for patients who continue to suffer from pain and stiffness despite standard care. It is typically used to delay surgical interventions, such as total knee replacement, providing interim relief for months at a time. While off-label use may occur in clinical practice, Synvisc is FDA-approved solely for use in the knee joint.

Contraindications

As with any injectable medication, Synvisc (3x2ml) has specific contraindications that must be carefully considered by healthcare professionals before treatment is administered. Namely, a patient should not use Synvisc to reduce osteoarthritis symptoms in the following cases:

• Hypersensitivity or allergy to hyaluronan products or avian proteins (such as those from bird feathers, eggs, or chicken products);
• Presence of skin disease or infections at the intended injection site;
• Active joint infections (septic arthritis or bacterial inflammation);
• Systemic infections or conditions that may compromise immunity or healing;
• Pregnancy or breastfeeding – use is not recommended due to limited safety data;
• Patients under 21 years of age.

Additionally, Synvisc should be avoided in joints other than the knee, including the hip, ankle, shoulder, or elbow, as safety and efficacy have not been established in those areas.

Expected Results

Synvisc does not act immediately, and it’s important to set appropriate expectations for osteoarthritis sufferers receiving the injection. Knee pain relief may begin to appear gradually, typically within 3 to 5 weeks following the final injection in the three-dose series. After completing the full series of Synvisc injections, a patient might expect the following results:

• Pain reduction: Noticeable improvement in joint pain and stiffness;
• Improved mobility and more extensive movement in the affected joint: Easier movement and increased physical activity tolerance;
• Prolonged efficacy: Relief that can last up to six months;
• Non-systemic action: Since Synvisc remains localized within the joint, it minimizes systemic side effects often seen with oral pain relievers.

Patients are encouraged to monitor their response to therapy and communicate with their healthcare provider if symptoms persist or worsen after treatment.

Possible Side Effects

When used to treat pain in joints, Synvisc is generally well-tolerated. At the same time, as with any medical treatment, side effects can occur. Most are mild and transient, resolving within a few days of injection.

Common side effects include:

• Injection site reactions, such as swelling, redness, warmth, or minor bruising;
• Joint stiffness or temporary increase in discomfort;
• Effusion (fluid buildup) in the treated knee;
• Mild allergic response, such as skin rash or itching.

Less common but serious adverse events are:

• Pseudo-septic reactions (severe inflammation mimicking infection);
• Infections if sterile injection protocols are not followed;
• Systemic hypersensitivity, though extremely rare.

If the formation of blood clots, high fever, severe swelling, extreme redness persistent pain beyond 72 hours, or such signs of allergic reactions as hives or difficulty breathing occur, immediate medical attention is necessary.

After-Treatment Recommendations

Following the administration of Synvisc, patients should observe several precautionary steps to ensure optimal outcomes and reduce the likelihood of adverse events. Here are the most relevant post-injection care tips a patient is recommended to follow after undergoing and injection of Synvisc:

• Rest the joint: Avoid strenuous activities for at least 48 hours post-injection;
• Apply ice: Use cold packs to minimize swelling or discomfort at the injection site;
• Avoid high-impact exercise: Running, jumping, or prolonged standing should be avoided in the first few days;
• Follow up: Return to the healthcare provider for any follow-up assessments or if symptoms persist.

Patients can usually resume normal daily activities within 1 to 2 days, depending on their individual recovery response.

Buy Synvics (3x2ml) and Other Osteoarthritis Treatments Online on OGOMED

If you’re a licensed healthcare provider searching for a trusted source of authentic injectable medications for osteoarthritis, OGOMED is your go-to destination. We proudly offer Synvisc (3x2ml) and a wide selection of other viscosupplements and joint care solutions, including Durolane, Orthovisc, and Hyalgan – all at competitive wholesale prices.

Why buy from OGOMED?

• 100% authentic and certified products;
• Bulk purchase discounts and affordable pricing;
• Fast and secure international shipping;
• Exceptional customer support tailored to medical professionals.

Register or log in to your OGOMED account to place an order today and take the next step in offering your patients the high-quality care they deserve.